BD India launches a TB Guardianship Program in collaboration with several partners including the Indian Chest Society (ICS), the Central TB Division (CTD), International Union Against Tuberculosis and Lung Disease (The Union), Corporate TB Pledge and USAID. The programme aims to improve TB diagnosis and Drug Susceptibility testing, says the company.
This three part webinar series will provide a platform for discussion and debate on key topics like – Understanding the Dynamic landscape of diagnosing and managing Drug-Resistant Tuberculosis (DR-TB); Emphasising the pivotal role of liquid culture and the efficacious management of tuberculosis (TB) and multidrug-resistant TB (MDR-TB) pivots on the expeditious diagnosis and precision in treating resistant infections amongst others.
At the conclusion of each series, participants will receive certificates as a token of their active participation. Additionally, exciting on-ground activities are planned at select Revised National Tuberculosis Control Program (RNCTP) sites.
Atul Grover, Managing Director, BD India/South Asia said, “We are committed to advancing the world of health through our TB Guardianship Program – an initiative geared to enhance effective TB diagnostic practices amongst healthcare professionals.
Dr Rakesh PS, Public Health Intervention Specialist at International Union Against Tuberculosis and Lung Disease said, “Our aim is to raise public awareness about the devastating health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic.”